KIP Infrastructure
2.23.2 - ci-build

KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.23.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions

: Immunoterapi - TTL Representation

Active as of 2022-07-18

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://hl7.org/fhir/ValueSet/Immunoterapi> a fhir:ValueSet ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:Resource.id [ fhir:value "Immunoterapi"] ;
  fhir:DomainResource.text [
     fhir:Narrative.status [ fhir:value "extensions" ] ;
     fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet Immunoterapi</b></p><a name=\"Immunoterapi\"> </a><a name=\"hcImmunoterapi\"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"CodeSystem-GenericValues.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><span title=\"Version is not explicitly stated, which means it is fixed to the version provided in this specification\"> version ?2.23.2</span><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-none\">none</a></td><td>Ingen immunoterapi</td><td>None - used to choose none of the available values</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-ATC.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><span title=\"Version is not explicitly stated, which means it is fixed to the version provided in this specification\"> version ?2.23.2</span><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA01\">L01FA01</a></td><td>Rituximab</td><td>L01FA01 - rituximab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA03\">L01FA03</a></td><td>Obinutuzumab</td><td>L01FA03 - obinutuzumab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FA02\">L01FA02</a></td><td>Ofatumumab</td><td>L01FA02 - ofatumumab</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L04AA\">L04AA</a></td><td>MabCampath</td><td>L04AA - Selective immunosuppressants</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FX05\">L01FX05</a></td><td>Brentuximab vedotin (Adcetris)</td><td>L01FX05 - brentuximab vedotin</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FX14\">L01FX14</a></td><td>Polatuzumab incl evt. Rituximab</td><td>L01FX14 - polatuzumab vedotin</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01FF\">L01FF</a></td><td>PD(L)1 hæmmere</td><td>L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-TreatmentUnspecified.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified</code></a><span title=\"Version is not explicitly stated, which means it is fixed to the version provided in this specification\"> version ?2.23.2</span><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-TreatmentUnspecified.html#TreatmentUnspecified-glofitamab\">glofitamab</a></td><td>Glofitamabel Epcoritamab Incl evt. Rituximab</td><td>Glofitamab</td></tr></table></li></ul></div>"
  ] ;
  fhir:ValueSet.url [ fhir:value "https://kip.rkkp.dk/fhir/ValueSet/Immunoterapi"] ;
  fhir:ValueSet.version [ fhir:value "2.23.2"] ;
  fhir:ValueSet.name [ fhir:value "Immunoterapi"] ;
  fhir:ValueSet.title [ fhir:value "Immunoterapi"] ;
  fhir:ValueSet.status [ fhir:value "active"] ;
  fhir:ValueSet.experimental [ fhir:value "true"^^xsd:boolean] ;
  fhir:ValueSet.date [ fhir:value "2022-07-18T00:00:00+02:00"^^xsd:dateTime] ;
  fhir:ValueSet.publisher [ fhir:value "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"] ;
  fhir:ValueSet.contact [
     fhir:index 0 ;
     fhir:ContactDetail.name [ fhir:value "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S" ] ;
     fhir:ContactDetail.telecom [
       fhir:index 0 ;
       fhir:ContactPoint.system [ fhir:value "url" ] ;
       fhir:ContactPoint.value [ fhir:value "https://trifork.com" ]
     ], [
       fhir:index 1 ;
       fhir:ContactPoint.system [ fhir:value "email" ] ;
       fhir:ContactPoint.value [ fhir:value "rbk@trifork.com" ]
     ]
  ] ;
  fhir:ValueSet.description [ fhir:value "Immunoterapi"] ;
  fhir:ValueSet.compose [
     fhir:ValueSet.compose.include [
       fhir:index 0 ;
       fhir:ValueSet.compose.include.system [ fhir:value "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues" ] ;
       fhir:ValueSet.compose.include.concept [
         fhir:index 0 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "none" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Ingen immunoterapi" ]
       ]
     ], [
       fhir:index 1 ;
       fhir:ValueSet.compose.include.system [ fhir:value "https://kip.rkkp.dk/fhir/CodeSystem/ATC" ] ;
       fhir:ValueSet.compose.include.concept [
         fhir:index 0 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01FA01" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Rituximab" ]
       ], [
         fhir:index 1 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01FA03" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Obinutuzumab" ]
       ], [
         fhir:index 2 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01FA02" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Ofatumumab" ]
       ], [
         fhir:index 3 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L04AA" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "MabCampath" ]
       ], [
         fhir:index 4 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01FX05" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Brentuximab vedotin (Adcetris)" ]
       ], [
         fhir:index 5 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01FX14" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Polatuzumab incl evt. Rituximab" ]
       ], [
         fhir:index 6 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "L01FF" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "PD(L)1 hæmmere" ]
       ]
     ], [
       fhir:index 2 ;
       fhir:ValueSet.compose.include.system [ fhir:value "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified" ] ;
       fhir:ValueSet.compose.include.concept [
         fhir:index 0 ;
         fhir:ValueSet.compose.include.concept.code [ fhir:value "glofitamab" ] ;
         fhir:ValueSet.compose.include.concept.display [ fhir:value "Glofitamabel Epcoritamab Incl evt. Rituximab" ]
       ]
     ]
  ] .

# - ontology header ------------------------------------------------------------

<http://hl7.org/fhir/ValueSet/Immunoterapi.ttl> a owl:Ontology ;
  owl:imports fhir:fhir.ttl ;
  owl:versionIRI <http://build.fhir.org/ValueSet/Immunoterapi.ttl> .